U.S. Patents Awarded to Inventors in Washington (Feb. 9)

(Targeted News Service Via Acquire Media NewsEdge) Targeted News Service Targeted News Service ALEXANDRIA, Va., Feb. 9 -- The following federal patents were awarded to inventors in Washington.

*** Microsoft Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Microsoft, Redmond, Wash., has been assigned a patent (8,369,251) developed by Vinod Prakash, Redmond, Wash., and Chao He, Redmond, Wash., for a "timestamp quality assessment for assuring acoustic echo canceller operability." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A voice communication end device provides echo reduction when operating in a full duplex mode using acoustic echo cancellation, which includes periodic audio queue adjustments to account for drift. The end device performs a quality assessment by calculating consistency statistics for the queue adjustments to determine whether acoustic echo cancellation would be ineffective, and if so falls back to a half duplex mode using voice switching." The patent application was filed on June 20, 2008 (12/143,625). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,69,251.PN.&OS=PN/83,69,251&RS=PN/83,69,251 Written by Amal Ahmed; edited by Jaya Anand.

*** Washington Biotech Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Washington Biotech, Spokane, Wash., has been assigned a patent (8,366,682) developed by Ronald E. Wyrick, Spokane, Wash., for medicine injection apparatuses.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Medicine injection apparatuses having multiple chambers. The chambers may be in lateral relationship. A torsional part is adapted to turn and be repositioned angularly relative to a main body to allow different chambers to be used to receive an injection assembly. The medicine injector can be constructed to administer multiple doses. The apparatuses may also have a storage chamber for storing the injection assembly after use. Plural drivers may be used to administer multiple doses, such as at the different angular positions of the torsional part. The apparatuses may allow multiple automatic injections from different angular positions and storage of an injector after use. Needle fright is reduced by minimizing exposure of an injection needle prior to injection." The patent application was filed on March 4, 2009 (12/380,954). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,66,682.PN.&OS=PN/83,66,682&RS=PN/83,66,682 Written by Amal Ahmed; edited by Jaya Anand.

*** Cardiac Pacemakers Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Cardiac Pacemakers, St. Paul, Minn., has been assigned a patent (8,366,629) developed by Gust H. Bardy, Seattle, for a "system and method for diagnosing and monitoring congestive heart failure." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A system for diagnosing and monitoring congestive heart failure for automated remote patient care is presented. A database stores a plurality of monitoring sets relating to patient information recorded on a substantially continuous basis. A server retrieving and processing the monitoring sets includes a comparison module determining patient status changes by comparing at least one recorded measure from one of the monitoring sets to at least one other recorded measure from another of the monitoring sets with both recorded measures relating to a type of patient information, and an analysis module testing each patient status change for one of an absence, an onset, a progression, a regression, and a status quo of congestive heart failure against a predetermined indicator threshold corresponding to a type of patient information as the recorded measures. The indicator threshold corresponds to a quantifiable physiological measure of a pathophysiology indicative of congestive heart failure. Hysteresis parameters may be used as a temporally-defined threshold for changes in pathophysiology." The patent application was filed on March 28, 2011 (13/073,301). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,66,629.PN.&OS=PN/83,66,629&RS=PN/83,66,629 Written by Amal Ahmed; edited by Jaya Anand.

*** Invention Science Fund I Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Invention Science Fund I, Bellevue, Wash., has been assigned a patent (8,366,686) developed by four co-inventors for a "subdermal material delivery device." The co-inventors are Roderick A. Hyde, Redmond, Wash., Jordin T. Kare, Seattle, Dennis J. Rivet, Portsmouth, Va., and Lowell L. Wood Jr., Bellevue, Wash.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method may include placing a first device on a first side of a skin portion of a subject and transferring a material through the skin portion of the subject from the first device to a subdermal second device disposed on a second side of the skin portion of the subject." The patent application was filed on April 3, 2008 (12/080,802). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,66,686.PN.&OS=PN/83,66,686&RS=PN/83,66,686 Written by Amal Ahmed; edited by Jaya Anand.

*** University of Washington Assigned Patent ALEXANDRIA, Va., Feb. 9 -- The University of Washington, Seattle, has been assigned a patent (8,366,619) developed by five co-inventors for "nodule screening using ultrasound elastography." The co-inventors are Yongmin Kim, Lake Forest Park, Wash., Manjiri Dighe, Bellevue, Wash., Si Luo, Seattle, Jae Kim, Torrance, Calif., and Eung-Hun Kim, Bothell, Wash.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A medical device is configured to diagnose whether a nodule of a bodily organ is malignant or benign using ultrasound elastography to determine a nodule stiffness index. Using either an external compression source or an in vivo pulsation source, the stiffness of the nodule of the bodily organ can be quantified by either its static properties or dynamic properties. The nodule can be classified as Type I, which is benign requiring further observation, or Type II, which is malignant requiring invasive procedures." The patent application was filed on May 13, 2010 (12/779,903). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,66,619.PN.&OS=PN/83,66,619&RS=PN/83,66,619 Written by Amal Ahmed; edited by Jaya Anand.

*** Benaroya Research Institute Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Benaroya Research Institute, Seattle, has been assigned a patent (8,367,619) developed by Thomas N. Wight, Seattle, and Mervyn Merrilees, Auckland, New Zealand, for "methods for promoting elastogenesis and elastin fiber formation by increasing tropoelastin expression." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Compositions and methods are provided for promoting elastin fiber formation (elastogenesis) in a cell, including methods that comprise contacting a cell that is capable of elastogenesis with (i) a mutated biglycan polypeptide that lacks chondroitin sulphate proteoglycan chains, (ii) a versican V3 isoform polypeptide that lacks most or all of the polypeptide regions encoded by one or more of exons 4, 5 or 6 or by exons 9-10 or 11-13, and/or with (iii) metastatin." The patent application was filed on Feb. 7, 2008 (12/526,625). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,367,619&OS=8,367,619&RS=8,367,619 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Sharp Laboratories Of America Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Sharp Laboratories Of America, Camas, Wash., has been assigned a patent (8,367,459) developed by Lisa H. Stecker, Vancouver, Wash., Kanan Puntambekar, Portland, Ore., and Kurt Ulmer, Vancouver, Wash., for an "organic semiconductor interface preparation." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method is provided for preparing an interface surface for the deposition of an organic semiconductor material, in the fabrication of an organic thin film transistor (OTFT). A substrate is provided and a gate electrode is formed overlying the substrate. A gate dielectric is formed overlying the gate electrode. Then, source (S) and drain (D) electrodes are formed overlying the gate dielectric, exposing a gate dielectric channel interface region between the S/D electrodes. Subsequent to exposing the OTFT to a H.sub.2 or N.sub.2 plasma, a self-assembled organic monolayer is formed overlying the S/D electrodes. Finally, an active organic semiconductor layer is formed over the S/D electrodes and gate dielectric channel interface. The OTFT may be exposed to plasma either before or after the formation of the S/D electrodes." The patent application was filed on Dec. 14, 2010 (12/968,102). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,367,459&OS=8,367,459&RS=8,367,459 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Invention Science Fund I Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Invention Science Fund I, Bellevue, Wash., has been assigned a patent (8,367,384) developed by five co-inventors for a bone semi-permeable device. The co-inventors are Ed Harlow, Boston, Edward K.Y. Jung, Las Vegas, Robert Langer, Newton, Mass., Eric C. Leuthardt, St. Louis, Lowell L. Wood Jr., Livermore, Wash.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Bone cages are disclosed including devices for biocompatible implantation. The structures of bone are useful for providing living cells and tissues as well as biologically active molecules to subjects." The patent application was filed on Oct. 15, 2007 (11/974,852). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,367,384&OS=8,367,384&RS=8,367,384 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Massachusetts Institute of Technology Assigned Patent for Methods and Apparatus for Control of Hydrothermal Nanowire Synthesis ALEXANDRIA, Va., Feb. 9 -- Massachusetts Institute of Technology, Cambridge, Mass., has been assigned a patent (8,367,435) developed by Brian Yichiun Chow, Cambridge, Mass., Jaebum Joo, Medford, Mass., and Manu Prakash, Arlington, Mass., for "methods and apparatus for control of hydrothermal nanowire synthesis." The abstract of the patent published by the U.S. Patent and Trademark Office states: "In exemplary implementations of this invention, hydrothermal synthesis of zinc oxide nanowires is morphologically controlled. Metal complex ions are used to suppress growth in a face-selective manner, by electrostatic crystal growth inhibition. This permits the aspect ratio (height/diameter) of the nanowires to be dynamically tuned over a wide range, from needle-like nanowires that are efficient field emitters to flattened nanowires with a platelet-like shape. The nanowire synthesis is all inorganic and occurs at low temperatures (e.g., <=60.degree. C.). The growth inhibition may be predictively modeled, using speciation plots and treating non-zinc complex ions as ligands. Microfluidic channels may be used for the synthesis, with different solutions flowing down different channels, permitting nanowires with different properties to be synthesized in parallel. This invention may be used to produce field emission devices and nanowire-embedded AC electroluminescent devices, and for in-situ fabrication of spatially complex integrated devices in a polymeric microfluidic system." The patent application was filed on Dec. 3, 2010 (12/960,182). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,367,435&OS=8,367,435&RS=8,367,435 Written by Satyaban Rath; edited by Hemanta Panigrahi.

For more information about Targeted News Service products and services, please contact: Myron Struck, editor, Targeted News Service LLC, Springfield, Va., 703/304-1897; editor@targetednews.com; http://targetednews.com.

-1113911 (c) 2013 Targeted News Service

[ Back To Technology News's Homepage ]